Trade Summary

4 days ago, Evnin Luke, serving as Dir at Werewolf Therapeutics, Inc. (HOWL), sold 78,377 shares at $0.62 per share, for a total transaction value of $48,431.00. Following this transaction, Evnin Luke now holds 2,472,297 shares of HOWL.

This sale represents a 3.00% decrease in Evnin Luke's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, December 30, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 3 days after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.